← Eichor
Condition: Histopathology Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Histopathology

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AI Model for Classifying Breast Cancer From Histopathology Images
Phase N/A · 1 location(s) · Taufiq Hasan, PhD · NCT06717984To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopatho
Phase N/A · 4 location(s) · XEOS Medical · NCT06970275Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Phase N/A · 10 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT06749600Hepatic Histopathology in Urea Cycle Disorders
Phase N/A · 2 location(s) · Baylor College of Medicine · NCT04908319Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04772456Comprehensive Esophageal Diagnostics Study
Phase 4 · 2 location(s) · Emory University · NCT04641702Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence
Phase N/A · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT04215224Histological Assessment of Tissue Penetration Depth of Argon Beam Coagulation in Ovarian Endometriomas
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT0771174399mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04857502[18F]PI-2620 Phase 3 Histopathological Study
Phase 3 · 25 location(s) · Lantheus Biosciences Ltd. · NCT05641688Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Phase N/A · 1 location(s) · Virdx, Inc. · NCT07432360A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Phase 1/Phase 2 · 2 location(s) · Antelope Surgical Solutions, Inc · NCT06906471Prospective Collection of Endoscopic and Histopathologic Data from Endoscopic Procedures Performed in UZ Gent
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT06467929Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Phase 3 · 2 location(s) · Region Västerbotten · NCT06565247Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
Phase N/A · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06364371Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
Phase N/A · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06707129Improving Outpatient Endometrial Biopsy Results
Phase N/A · 1 location(s) · Cairo University · NCT06694246KIA-Korekt: Staged Unimodal-to-Multimodal AI Evaluation for Perioperative Risk Prediction in Colorectal Cancer
Phase N/A · 1 location(s) · Rene Mantke · NCT07537491FAPI PET for Lung Fibrosis
EARLY_Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05365802Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas
Phase N/A · 1 location(s) · Kanazawa University · NCT07215130Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07588854Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
NA · 1 location(s) · IRCCS San Raffaele · NCT06516237Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Phase 2 · 1 location(s) · David W. Roberts · NCT02691923Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
Phase N/A · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT04217044Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
Phase 2 · 5 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06740526
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.